BE2016C041I2 - - Google Patents
Download PDFInfo
- Publication number
- BE2016C041I2 BE2016C041I2 BE2016C041C BE2016C041C BE2016C041I2 BE 2016C041 I2 BE2016C041 I2 BE 2016C041I2 BE 2016C041 C BE2016C041 C BE 2016C041C BE 2016C041 C BE2016C041 C BE 2016C041C BE 2016C041 I2 BE2016C041 I2 BE 2016C041I2
- Authority
- BE
- Belgium
- Prior art keywords
- hydroxypyrone
- iron
- reacting
- carboxylic acid
- aqueous solution
- Prior art date
Links
- LIPRKYKMVQPYPG-UHFFFAOYSA-N 3-Hydroxy-2H-pyran-2-one Chemical compound OC1=CC=COC1=O LIPRKYKMVQPYPG-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 150000002505 iron Chemical class 0.000 abstract 1
- -1 iron hydroxypyrone compound Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Iron (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0211500.4A GB0211500D0 (en) | 2002-05-18 | 2002-05-18 | Method of forming iron hydroxypyrone compounds |
| PCT/GB2003/001956 WO2003097627A1 (en) | 2002-05-18 | 2003-05-07 | Method of forming iron hydroxypyrone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE2016C041I2 true BE2016C041I2 (enrdf_load_stackoverflow) | 2022-08-09 |
Family
ID=9936987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE2016C041C BE2016C041I2 (enrdf_load_stackoverflow) | 2002-05-18 | 2016-08-17 |
Country Status (11)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8952061B2 (en) * | 2006-08-22 | 2015-02-10 | University Of Virginia Patent Foundation | Methods and compounds regulating the erythroid response to iron deficiency |
| GB2451713B (en) | 2007-02-06 | 2009-12-16 | Medical Res Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
| GB0808835D0 (en) | 2008-05-15 | 2008-06-18 | Vitra Pharmaceuticals Ltd | Therapeutic compositions |
| US8536106B2 (en) | 2010-04-14 | 2013-09-17 | Ecolab Usa Inc. | Ferric hydroxycarboxylate as a builder |
| GB201101370D0 (en) | 2011-01-27 | 2011-03-09 | Iron Therapeutics Holdings Ag | Process |
| GB201404390D0 (en) * | 2014-03-12 | 2014-04-23 | Iron Therapeutics Holdings Ag | Composition |
| WO2015198304A1 (en) | 2014-06-22 | 2015-12-30 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| GB2531742B (en) * | 2014-10-28 | 2016-10-05 | Iron Therapeutics Holdings Ag | Polymorphs of ferric maltol |
| GB201517893D0 (en) | 2015-10-09 | 2015-11-25 | Medical Res Council | Methods for producing carboxylate ligand modified ferric iron hydroxide colloids |
| WO2017167963A1 (en) * | 2016-03-31 | 2017-10-05 | Medical Research Council | Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides |
| AU2017242906B2 (en) * | 2016-03-31 | 2020-11-19 | Shield TX (UK) Limited | Methods for producing Ferric maltol compositions from Ferrous Hydroxides |
| US11406664B2 (en) | 2016-03-31 | 2022-08-09 | Shield TX (UK) Limited | Ferric maltol compositions for use in the treatment or prevention of cancer and tumours |
| US11155529B2 (en) | 2016-03-31 | 2021-10-26 | Shield TX (UK) Limited | Methods for producing ferric maltol compositions from elemental iron |
| GB202005054D0 (en) | 2020-04-06 | 2020-05-20 | Nemysis Ltd | Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases |
| CN112574158B (zh) * | 2020-12-29 | 2022-08-02 | 南京百泽医药科技有限公司 | 一种麦芽酚铁晶型ii及其制备方法 |
| CN115177625A (zh) * | 2022-06-28 | 2022-10-14 | 金陵药业股份有限公司 | 一种羧基麦芽糖铁药用组合物及其制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3130204A (en) * | 1962-02-07 | 1964-04-21 | Pfizer & Co C | Preparation of gamma-pyrones |
| FR1500765A (fr) * | 1963-09-19 | 1967-11-10 | Pfizer & Co C | Dérivés de l'acide pyroméconique et procédé pour leur préparation |
| SE322866B (enrdf_load_stackoverflow) * | 1966-12-15 | 1970-04-20 | Astra Ab | |
| US4018907A (en) * | 1975-08-25 | 1977-04-19 | General Foods Corporation | Coloring food with iron-complexes |
| US4212685A (en) * | 1978-12-11 | 1980-07-15 | Lea Manufacturing Company | Protective and color receptive coating for aluminum |
| US4279936A (en) * | 1979-09-24 | 1981-07-21 | William Underwood Company | Maltol treated canned meat process |
| DE3365971D1 (en) * | 1982-03-24 | 1986-10-16 | Nat Res Dev | Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives |
| GR78491B (enrdf_load_stackoverflow) | 1982-03-24 | 1984-09-27 | Nat Res Dev | |
| GB2128998B (en) * | 1982-10-22 | 1986-07-16 | Nat Res Dev | Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone |
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8325494D0 (en) | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| US4912118A (en) | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
| USRE34313E (en) | 1983-09-23 | 1993-07-13 | National Research Development Corporation | Pharmaceutical compositions |
| GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| GB8329043D0 (en) * | 1983-10-31 | 1983-11-30 | Hider R C | Pharmaceutical compositions |
| GB8410290D0 (en) | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
| US5177068A (en) | 1984-04-19 | 1993-01-05 | National Research Development Corporation | Pharmaceutical compositions |
| GB8410289D0 (en) | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
| GB8606913D0 (en) | 1986-03-20 | 1986-04-23 | Hider R C | Treatment of sickle cell disease |
| JPH0367565A (ja) | 1989-08-07 | 1991-03-22 | Kansai Paint Co Ltd | 鉄分強化食品 |
| GB9209078D0 (en) | 1992-04-27 | 1992-06-10 | Hider Robert C | Pharmaceutical compositions |
| GB9217099D0 (en) | 1992-08-12 | 1992-09-23 | British Tech Group | Pharmaceutical compositions |
| WO1996041627A2 (en) | 1995-06-10 | 1996-12-27 | Vitra Pharmaceuticals Ltd | Iron compounds, compositions, methods of making the same and uses thereof |
| GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
-
2002
- 2002-05-18 GB GBGB0211500.4A patent/GB0211500D0/en not_active Ceased
-
2003
- 2003-05-07 AU AU2003233881A patent/AU2003233881A1/en not_active Abandoned
- 2003-05-07 AT AT03727643T patent/ATE352547T1/de not_active IP Right Cessation
- 2003-05-07 ES ES03727643T patent/ES2283771T3/es not_active Expired - Lifetime
- 2003-05-07 WO PCT/GB2003/001956 patent/WO2003097627A1/en active Search and Examination
- 2003-05-07 EP EP03727643A patent/EP1506183B1/en not_active Expired - Lifetime
- 2003-05-07 CA CA2483067A patent/CA2483067C/en not_active Expired - Lifetime
- 2003-05-07 US US10/514,836 patent/US7459569B2/en not_active Expired - Lifetime
- 2003-05-07 DE DE60311456T patent/DE60311456T2/de not_active Expired - Lifetime
-
2016
- 2016-08-09 FR FR16C0033C patent/FR16C0033I2/fr active Active
- 2016-08-17 BE BE2016C041C patent/BE2016C041I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2483067C (en) | 2011-04-26 |
| EP1506183A1 (en) | 2005-02-16 |
| ATE352547T1 (de) | 2007-02-15 |
| GB0211500D0 (en) | 2002-06-26 |
| US20050250754A1 (en) | 2005-11-10 |
| DE60311456T2 (de) | 2007-11-15 |
| AU2003233881A1 (en) | 2003-12-02 |
| WO2003097627A1 (en) | 2003-11-27 |
| US7459569B2 (en) | 2008-12-02 |
| DE60311456D1 (de) | 2007-03-15 |
| FR16C0033I1 (enrdf_load_stackoverflow) | 2016-09-23 |
| ES2283771T3 (es) | 2007-11-01 |
| EP1506183B1 (en) | 2007-01-24 |
| FR16C0033I2 (fr) | 2018-01-19 |
| CA2483067A1 (en) | 2003-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE2016C041I2 (enrdf_load_stackoverflow) | ||
| EP1141444A4 (en) | NEW COMPOSITION FOR SELECTIVE ETCHING OF OXIDES ON METALS | |
| EP2272825A3 (en) | N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation | |
| MXPA03009565A (es) | Derivado de acido carboxilico y una sal del mismo. | |
| MXPA01002392A (es) | Metodos y composiciones acidificadas para reducir la corrosion en las superficies de metal y la precipitacion del sulfuro. | |
| ZA200308319B (en) | Method for producing an aqueous acrylamide solution with a biocatalyst. | |
| ATE469164T1 (de) | Modifizierte l-nukleinsäure | |
| MXPA03000510A (es) | Sales estables de acido o-acetilsalicilico con aminoacidos basicos. | |
| CY1108593T1 (el) | Συμπυκνωμενο υδατικο διαλυμα αμβροξολης | |
| AU3309995A (en) | Water soluble cyclic amine-dicarboxylic acid-alkanol amine salt corrosion inhibitor | |
| WO2003062344A3 (en) | Acidizing and scale treatment of subterranean formation | |
| PL365213A1 (en) | Enteric ketoacid salts and amino acids | |
| WO2002024001A3 (de) | Tierfuttersupplement enthaltend d-pantothensäure und/oder deren salze, verbessertes verfahren zu dessen herstellung sowie dessen verwendung | |
| PL358298A1 (en) | Process for the preparation of alkaline earth salts of d-pantothenic acid | |
| IL157402A0 (en) | Method for producing d-pantothenic acid and/or salts therefor as an additive for animal feed | |
| NZ334940A (en) | process of producing 4-(des-dimethylamino)-tetracycline | |
| IN2003CH01298A (en) | Method for producing D-pantothenic acid and/or salt thereof as additive for animal feesdstuffs | |
| IN2003CH01315A (en) | Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed | |
| AU2002250978A1 (en) | Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed | |
| BG102347A (en) | New carboxylic acid derivatives, method for their preparation and application | |
| AU2001249606A1 (en) | Method of cyanide salt production | |
| RU2000109795A (ru) | Способ получения магнитоактивного соединения | |
| YU71302A (sh) | Postupak za formiranje amidne veze | |
| MXPA04000513A (es) | Proceso para la preparacion de 4-metilamino-4-fenilpiperidina. | |
| ZA947052B (en) | Intravenously administrable aqueous solution |